Stockscreener 앱 받기
5.13
6.65%
0.32
시간 외 거래:
5.13
Cogent Biosciences Inc 주식(COGT)의 최신 뉴스
10 Best Low-Priced Biotech Stocks to Buy Now - Insider Monkey
Q2 EPS Estimate for Cogent Biosciences Lifted by Analyst - Defense World
Dimensional Fund Advisors LP Lowers Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Research Analysts Offer Predictions for COGT FY2028 Earnings - Defense World
Robert W. Baird Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $7.00 - Defense World
Cogent Biosciences (NASDAQ:COGT) Releases Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Stock Surge: Cogent Biosciences Inc (COGT) Closes at 4.70, Marking a -15.62 Increase/Decrease - DWinneX
Cogent Biosciences (COGT) Maintains Neutral Rating Amid PT Adjustment | COGT Stock News - GuruFocus
Cogent Biosciences (COGT) Price Target Reduced by Baird | COGT Stock News - GuruFocus
Cogent Biosciences Advances with Promising Clinical Trials - TipRanks
MetLife Investment Management LLC Has $443,000 Stock Holdings in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Invesco Ltd. Sells 455,437 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat
Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference - Barchart.com
Wedbush Trims Price Target on Cogent Biosciences to $10 From $11, Maintains Neutral Rating - marketscreener.com
Cogent Biosciences Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Cogent Biosciences Inc (COGT) Q1 2025 Earnings: EPS Misses at -0 - GuruFocus
Cogent Biosciences (COGT) Plans Strategic Data Announcements in 2025 | COGT Stock News - GuruFocus
Cogent Biosciences Reports First Quarter 2025 Financial Results - GlobeNewswire
Form 424B5 Cogent Biosciences, Inc. - StreetInsider
BRIEF-Cogent Biosciences Q1 Income From Operations USD -74.933 Million - TradingView
Cogent Biosciences Gears Up for 3 Major Clinical Trial Readouts in 2025, Maintains Strong $245M Cash Reserve - Stock Titan
Wells Fargo & Company MN Acquires 14,413 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
(COGT) Trading Signals - news.stocktradersdaily.com
Is Cogent Biosciences, Inc. (COGT) the Best Small Cap Stock to Buy with the Biggest Upside Potential? - Insider Monkey
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Invesco Ltd. - Defense World
Barclays PLC Has $1.51 Million Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Sees Unusually High Options Volume (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc [COGT] Records 200-Day SMA of $8.76 - knoxdaily.com
JPMorgan Chase & Co. Decreases Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Get in on Cogent Biosciences Inc’s (COGT) buy-in window today! - Sete News
Legal & General Group Plc Has $542,000 Stock Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences Inc (COGT) Stock: The Story of a 52-Week Stock Range - investchronicle.com
Financial Metrics Check: Cogent Biosciences Inc (COGT)’s Ratios for Trailing Twelve Months - DWinneX
Results from Cogent Biosciences Inc (COGT) show potential - uspostnews.com
Understanding the Risks of Investing in Cogent Biosciences Inc (COGT) - knoxdaily.com
Let’s Jump Into The Cogent Biosciences Inc (NASDAQ: COGT) Stock Forecast - Marketing Sentinel
Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.43 Consensus Target Price from Brokerages - Defense World
Cogent Appoints New Senior Executives to Lead Market Access and Corporate Strategy | COGT Stock News - GuruFocus
Cogent Biosciences Presents Four Posters at the American Associa - GuruFocus
Cogent Biosciences (COGT) Unveils Promising Preclinical Data on Cancer Inhibitors | COGT Stock News - GuruFocus
Cogent Biosciences, Inc. Unveils Preclinical Data from Four Pipeline Programs at AACR 2025 Annual Meeting - Nasdaq
Cogent Biosciences Presents Four Posters at the American - GlobeNewswire
Breakthrough: Cogent's Cancer Drug Achieves 90% Tumor Inhibition, Plus 3 More Pipeline Advances - Stock Titan
Cogent Biosciences Inc [COGT] Records 50-Day SMA of $6.47 - knoxdaily.com
Perhaps timely catching Cogent Biosciences Inc (COGT) would be a good idea - Sete News
Metric Analysis: Cogent Biosciences Inc (COGT)’s Key Ratios in the Limelight - DWinneX
Cogent Biosciences Inc (COGT) did well last session? - uspostnews.com
Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - knoxdaily.com
(COGT) Technical Data - news.stocktradersdaily.com
Cogent Biosciences (COGT): Among the Most Promising Penny Stocks According to Analysts - Insider Monkey
Geode Capital Management LLC Boosts Stake in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Is Cogent Biosciences Inc. (NASDAQ:COGT) the Best Biotech Penny Stock to Buy According to Hedge Funds? - Insider Monkey
Gastrointestinal Stromal Tumor Market to Grow Rapidly During the Study Period (2020–2034) Owing to the Launch of Emerging Therapies | DelveInsight - GlobeNewswire Inc.
Vanguard Group Inc. Purchases 418,975 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Wellington Management Group LLP Trims Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
KLP Kapitalforvaltning AS Takes $88,000 Position in Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World
Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Sold by Corebridge Financial Inc. - Defense World
Cogent: Several 2025 Readouts On Deck With Bezuclastinib Advancement - Seeking Alpha
4.10%
자본화:
|
볼륨(24시간):